Literature DB >> 1778850

Molecular evolution of tetracycline-resistance plasmids carrying TetM found in Neisseria gonorrhoeae from different countries.

D M Gascoyne1, J Heritage, P M Hawkey, A Turner, B van Klingeren.   

Abstract

High level tetracycline resistant strains of Neisseria gonorrhoeae (TRNG) have been shown to carry a 40.6 kb (25.2 MDa) conjugative plasmid with a Class M tetracycline resistance determinant. Restriction endonuclease analysis mapping showed that there were at least two different TRNG plasmid types which were found in geographically distinct locations. The physical maps of these two plasmids were compared to a gonococcal conjugative plasmid which did not encode tetracycline resistance. The plasmid type which is endemic in the Netherlands was found to be closely related to the gonococcal conjugative plasmid, which supports the established hypothesis that the 40.6 kb plasmid has evolved by transposition of the TetM determinant into the conjugative plasmid. The plasmid found in the United States has either evolved by substantial divergent evolution or it results from a different transposition event. In the UK there have been isolations of TRNGs carrying either of the two plasmid types reflecting a flow of people both across the Atlantic and in Europe. It is possible that further TetM-containing plasmids will be found in N. gonorrhoeae paralleling the family of TEM beta-lactamase encoding plasmids already described.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1778850     DOI: 10.1093/jac/28.2.173

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  15 in total

1.  Molecular epidemiology of tetM genes in Neisseria gonorrhoeae.

Authors:  A Turner; K R Gough; J P Leeming
Journal:  Sex Transm Infect       Date:  1999-02       Impact factor: 3.519

2.  World-wide distribution of high level tetracycline-resistant Neisseria gonorrhoeae.

Authors:  D M Gascoyne-Binzi; P M Hawkey; J Heritage; A Turner; M Nadarajah
Journal:  Genitourin Med       Date:  1992-08

3.  Changing antimicrobial susceptibility and molecular characterisation of Neisseria gonorrhoeae isolates in Guangdong, China: in a background of rapidly rising epidemic.

Authors:  Xiaolin Qin; Yunhu Zhao; Wei Chen; Xingzhong Wu; Sanmei Tang; Guozhou Li; Yu Yuqi; Wenling Cao; Xiaofeng Liu; Jinmei Huang; Jieyi Yang; Wentao Chen; Weiming Tang; Heping Zheng
Journal:  Int J Antimicrob Agents       Date:  2019-08-16       Impact factor: 5.283

4.  The virgin population of Neisseria gonorrhoeae in Stockholm has decreased and antimicrobial resistance is increasing.

Authors:  M Bäckman; K Jacobson; S Ringertz
Journal:  Genitourin Med       Date:  1995-08

5.  Surveillance of antibiotic resistance in Neisseria gonorrhoeae in The Netherlands, 1977-95.

Authors:  M J van de Laar; Y T van Duynhoven; M Dessens; M van Santen; B van Klingeren
Journal:  Genitourin Med       Date:  1997-12

Review 6.  Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and future.

Authors:  Magnus Unemo; William M Shafer
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

7.  WGS to predict antibiotic MICs for Neisseria gonorrhoeae.

Authors:  David W Eyre; Dilrini De Silva; Kevin Cole; Joanna Peters; Michelle J Cole; Yonatan H Grad; Walter Demczuk; Irene Martin; Michael R Mulvey; Derrick W Crook; A Sarah Walker; Tim E A Peto; John Paul
Journal:  J Antimicrob Chemother       Date:  2017-07-01       Impact factor: 5.790

8.  Auxotypes and serogroups of tetracycline-resistant Neisseria gonorrhoeae isolated in Malaysia.

Authors:  A S Koay; R My; Y M Cheong
Journal:  J Clin Microbiol       Date:  1996-07       Impact factor: 5.948

Review 9.  Applications of genomics to slow the spread of multidrug-resistant Neisseria gonorrhoeae.

Authors:  Tatum D Mortimer; Yonatan H Grad
Journal:  Ann N Y Acad Sci       Date:  2018-06-06       Impact factor: 5.691

10.  Conjugative plasmids of Neisseria gonorrhoeae.

Authors:  Emilia Pachulec; Chris van der Does
Journal:  PLoS One       Date:  2010-04-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.